ReP USP - Resultado da busca

Artigo de periodico
Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity (2021)
Nunes, Paulo Sergio Gonçalves; Silva, Gabriel da ; Nascimento, Sofia; Mantoani, Susimaire Pedersoli; Andrade, Peterson de; Bernardes, Emerson Soares; Kawano, Daniel Fábio; Leopoldino, Andréia Machado ; Carvalho, Ivone
Source: Bioorganic Chemistry. Unidades: IPEN, FCFRP
Subjects: ANTINEOPLÁSICOS, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, PROTEÍNAS QUINASES, ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Paulo Sergio Gonçalves et al. Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity. Bioorganic Chemistry, v. 113, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bioorg.2021.104982. Acesso em: 01 nov. 2024.
APA
Nunes, P. S. G., Silva, G. da, Nascimento, S., Mantoani, S. P., Andrade, P. de, Bernardes, E. S., et al. (2021). Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity. Bioorganic Chemistry, 113. doi:10.1016/j.bioorg.2021.104982
NLM
Nunes PSG, Silva G da, Nascimento S, Mantoani SP, Andrade P de, Bernardes ES, Kawano DF, Leopoldino AM, Carvalho I. Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity [Internet]. Bioorganic Chemistry. 2021 ; 113[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bioorg.2021.104982
Vancouver
Nunes PSG, Silva G da, Nascimento S, Mantoani SP, Andrade P de, Bernardes ES, Kawano DF, Leopoldino AM, Carvalho I. Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity [Internet]. Bioorganic Chemistry. 2021 ; 113[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bioorg.2021.104982
Artigo de periodico
Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents (2021)
Gaspari, Ana Paula Segantin ; Silva, Roberto Santana da; Carneiro, Zumira Aparecida; Carvalho, Marcelo Rodrigues de; Carvalho, Ivone ; Pernomian, Laena ; Ferreira, Lucimara P.; Ramos, Loyanne Carla Barbosa; Souza, Gabriel Aguiar de; Formiga, André Luiz Barboza
Source: Anti-Cancer Agents in Medicinal Chemistry. Unidades: FCFRP, FMRP
Subjects: AMINOÁCIDOS, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPARI, Ana Paula Segantin et al. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents. Anti-Cancer Agents in Medicinal Chemistry, v. 21, n. 12, p. 1602-1611, 2021Tradução . . Disponível em: https://doi.org/10.2174/0929867327666201020155105. Acesso em: 01 nov. 2024.
APA
Gaspari, A. P. S., Silva, R. S. da, Carneiro, Z. A., Carvalho, M. R. de, Carvalho, I., Pernomian, L., et al. (2021). Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents. Anti-Cancer Agents in Medicinal Chemistry, 21( 12), 1602-1611. doi:10.2174/0929867327666201020155105
NLM
Gaspari APS, Silva RS da, Carneiro ZA, Carvalho MR de, Carvalho I, Pernomian L, Ferreira LP, Ramos LCB, Souza GA de, Formiga ALB. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2021 ; 21( 12): 1602-1611.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/0929867327666201020155105
Vancouver
Gaspari APS, Silva RS da, Carneiro ZA, Carvalho MR de, Carvalho I, Pernomian L, Ferreira LP, Ramos LCB, Souza GA de, Formiga ALB. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2021 ; 21( 12): 1602-1611.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/0929867327666201020155105
Artigo de periodico
Non-cytotoxic 1,2,3-triazole tethered fused heterocyclic ring derivatives display Tax protein inhibition and impair HTLV-1 infected cells (2020)
Santos, Daiane Fernanda dos; Pilger, Denise Regina Bairros de; Vandermeulen, Charlotte; Khouri, Ricardo; Mantoani, Susimaire Pedersoli; Nunes, Paulo Sergio Gonçalves; Andrade, Peterson de; Carvalho, Ivone ; Casseb, Jorge Simão do Rosário ; Twizere, Jean-Claude; Willems, Luc; Freitas Junior, Lucio Holanda Gondim de; Haddad, Simone Kashima
Source: Bioorganic & Medicinal Chemistry. Unidades: FCFRP, FM, ICB, FMRP
Subjects: APOPTOSE, PROLIFERAÇÃO CELULAR, VÍRUS, RETROVIRIDAE, NEOPLASIAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Daiane Fernanda dos et al. Non-cytotoxic 1,2,3-triazole tethered fused heterocyclic ring derivatives display Tax protein inhibition and impair HTLV-1 infected cells. Bioorganic & Medicinal Chemistry, v. 28, n. 22, p. 1-9, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2020.115746. Acesso em: 01 nov. 2024.
APA
Santos, D. F. dos, Pilger, D. R. B. de, Vandermeulen, C., Khouri, R., Mantoani, S. P., Nunes, P. S. G., et al. (2020). Non-cytotoxic 1,2,3-triazole tethered fused heterocyclic ring derivatives display Tax protein inhibition and impair HTLV-1 infected cells. Bioorganic & Medicinal Chemistry, 28( 22), 1-9. doi:10.1016/j.bmc.2020.115746
NLM
Santos DF dos, Pilger DRB de, Vandermeulen C, Khouri R, Mantoani SP, Nunes PSG, Andrade P de, Carvalho I, Casseb JS do R, Twizere J-C, Willems L, Freitas Junior LHG de, Haddad SK. Non-cytotoxic 1,2,3-triazole tethered fused heterocyclic ring derivatives display Tax protein inhibition and impair HTLV-1 infected cells [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 22): 1-9.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bmc.2020.115746
Vancouver
Santos DF dos, Pilger DRB de, Vandermeulen C, Khouri R, Mantoani SP, Nunes PSG, Andrade P de, Carvalho I, Casseb JS do R, Twizere J-C, Willems L, Freitas Junior LHG de, Haddad SK. Non-cytotoxic 1,2,3-triazole tethered fused heterocyclic ring derivatives display Tax protein inhibition and impair HTLV-1 infected cells [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 22): 1-9.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bmc.2020.115746
Artigo de periodico
Antitumour anthracyclines: progress and perspectives (2020)
Martins-Teixeira, Maristela B.; Carvalho, Ivone
Source: ChemMedChem. Unidade: FCFRP
Subjects: QUIMIOTERÁPICOS, NEOPLASIAS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS-TEIXEIRA, Maristela B. e CARVALHO, Ivone. Antitumour anthracyclines: progress and perspectives. ChemMedChem, v. 15, n. 11, p. 933-948, 2020Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202000131. Acesso em: 01 nov. 2024.
APA
Martins-Teixeira, M. B., & Carvalho, I. (2020). Antitumour anthracyclines: progress and perspectives. ChemMedChem, 15( 11), 933-948. doi:10.1002/cmdc.202000131
NLM
Martins-Teixeira MB, Carvalho I. Antitumour anthracyclines: progress and perspectives [Internet]. ChemMedChem. 2020 ; 15( 11): 933-948.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/cmdc.202000131
Vancouver
Martins-Teixeira MB, Carvalho I. Antitumour anthracyclines: progress and perspectives [Internet]. ChemMedChem. 2020 ; 15( 11): 933-948.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/cmdc.202000131
Artigo de periodico
Synthesis of MUC1-derived glycopeptide bearing a novel triazole STn analog (2020)
Marchiori, Marcelo Fiori; Bortot, Leandro Oliveira; Carvalho, Ivone ; Campo, Vanessa Leiria
Source: Carbohydrate Research. Unidade: FCFRP
Subjects: GLICOPEPTÍDEOS, SISTEMA IMUNE, IMUNOTERAPIA, NEOPLASIAS, PROTEÍNAS, ANTÍGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCHIORI, Marcelo Fiori et al. Synthesis of MUC1-derived glycopeptide bearing a novel triazole STn analog. Carbohydrate Research, v. 498, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.carres.2020.108155. Acesso em: 01 nov. 2024.
APA
Marchiori, M. F., Bortot, L. O., Carvalho, I., & Campo, V. L. (2020). Synthesis of MUC1-derived glycopeptide bearing a novel triazole STn analog. Carbohydrate Research, 498, 1-11. doi:10.1016/j.carres.2020.108155
NLM
Marchiori MF, Bortot LO, Carvalho I, Campo VL. Synthesis of MUC1-derived glycopeptide bearing a novel triazole STn analog [Internet]. Carbohydrate Research. 2020 ; 498 1-11.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.carres.2020.108155
Vancouver
Marchiori MF, Bortot LO, Carvalho I, Campo VL. Synthesis of MUC1-derived glycopeptide bearing a novel triazole STn analog [Internet]. Carbohydrate Research. 2020 ; 498 1-11.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.carres.2020.108155
Artigo de periodico
Novel hybrid acetylcholinesterase inhibitors induce differentiation and neuritogenesis in neuronal cells in vitro through activation of the AKT pathway (2020)
Moreira, Natália Chermont dos Santos ; Lima, Jéssica Ellen Barbosa de Freitas ; Chierrito, Talita Perez Cantuaria; Carvalho, Ivone ; Sakamoto-Hojo, Elza Tiemi
Source: Journal of Alzheimer's Disease. Unidades: FMRP, FCFRP, FFCLRP
Subjects: DOENÇA DE ALZHEIMER, CÉLULAS, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Natália Chermont dos Santos et al. Novel hybrid acetylcholinesterase inhibitors induce differentiation and neuritogenesis in neuronal cells in vitro through activation of the AKT pathway. Journal of Alzheimer's Disease, v. 78, n. 1, p. 353-370, 2020Tradução . . Disponível em: https://doi.org/10.3233/JAD-200425. Acesso em: 01 nov. 2024.
APA
Moreira, N. C. dos S., Lima, J. E. B. de F., Chierrito, T. P. C., Carvalho, I., & Sakamoto-Hojo, E. T. (2020). Novel hybrid acetylcholinesterase inhibitors induce differentiation and neuritogenesis in neuronal cells in vitro through activation of the AKT pathway. Journal of Alzheimer's Disease, 78( 1), 353-370. doi:10.3233/JAD-200425
NLM
Moreira NC dos S, Lima JEB de F, Chierrito TPC, Carvalho I, Sakamoto-Hojo ET. Novel hybrid acetylcholinesterase inhibitors induce differentiation and neuritogenesis in neuronal cells in vitro through activation of the AKT pathway [Internet]. Journal of Alzheimer's Disease. 2020 ; 78( 1): 353-370.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3233/JAD-200425
Vancouver
Moreira NC dos S, Lima JEB de F, Chierrito TPC, Carvalho I, Sakamoto-Hojo ET. Novel hybrid acetylcholinesterase inhibitors induce differentiation and neuritogenesis in neuronal cells in vitro through activation of the AKT pathway [Internet]. Journal of Alzheimer's Disease. 2020 ; 78( 1): 353-370.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3233/JAD-200425
Artigo de periodico
Copper reactivity can be tuned to catalyze the stereoselective synthesis of 2-deoxyglycosides from glycals (2020)
Palo-Nieto, Carlos; Sau, Abhijit; Jeanneret, Robin; Payard, Pierre-Adrien; Salamé, Aude; Teixeira, Maristela Braga; Carvalho, Ivone ; Grimaud, Laurence; Galan, M. Carmen
Source: Organic Letters. Unidade: FCFRP
Subjects: COBRE, CATÁLISE, QUÍMICA ORGÂNICA, CARBOIDRATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALO-NIETO, Carlos et al. Copper reactivity can be tuned to catalyze the stereoselective synthesis of 2-deoxyglycosides from glycals. Organic Letters, v. 22, n. 5, p. 1991-1996, 2020Tradução . . Disponível em: https://doi.org/10.1021/acs.orglett.9b04525. Acesso em: 01 nov. 2024.
APA
Palo-Nieto, C., Sau, A., Jeanneret, R., Payard, P. -A., Salamé, A., Teixeira, M. B., et al. (2020). Copper reactivity can be tuned to catalyze the stereoselective synthesis of 2-deoxyglycosides from glycals. Organic Letters, 22( 5), 1991-1996. doi:10.1021/acs.orglett.9b04525
NLM
Palo-Nieto C, Sau A, Jeanneret R, Payard P-A, Salamé A, Teixeira MB, Carvalho I, Grimaud L, Galan MC. Copper reactivity can be tuned to catalyze the stereoselective synthesis of 2-deoxyglycosides from glycals [Internet]. Organic Letters. 2020 ; 22( 5): 1991-1996.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1021/acs.orglett.9b04525
Vancouver
Palo-Nieto C, Sau A, Jeanneret R, Payard P-A, Salamé A, Teixeira MB, Carvalho I, Grimaud L, Galan MC. Copper reactivity can be tuned to catalyze the stereoselective synthesis of 2-deoxyglycosides from glycals [Internet]. Organic Letters. 2020 ; 22( 5): 1991-1996.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1021/acs.orglett.9b04525
Artigo de periodico
Targeted uptake of folic acid-functionalized polymeric nanoparticles loading glycoalkaloidic extract in vitro and in vivo assays (2020)
Miranda, Mariza Abreu; Silva, Letícia Bueno; Carvalho, Ivone ; Amaral, Robson Luis Ferraz do; Paula, M. H.; Swiech, Kamilla ; Bastos, Jairo Kenupp ; Paschoal, Jonas Augusto Rizzato ; Emery, Flavio da Silva ; Reis, Rodolfo Borges dos ; Bentley, Maria Vitória Lopes Badra; Gaspari, Priscyla Daniely Marcato
Source: Colloids and Surfaces B: Biointerfaces. Unidades: FCFRP, FMRP
Subjects: NANOPARTÍCULAS, BIOMATERIAIS POLIMÉRICOS, NEOPLASIAS DA BEXIGA, ÁCIDO FÓLICO, EXTRATOS (FORMAS FARMACÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Mariza Abreu et al. Targeted uptake of folic acid-functionalized polymeric nanoparticles loading glycoalkaloidic extract in vitro and in vivo assays. Colloids and Surfaces B: Biointerfaces, v. 192, p. 1-8, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2020.111106. Acesso em: 01 nov. 2024.
APA
Miranda, M. A., Silva, L. B., Carvalho, I., Amaral, R. L. F. do, Paula, M. H., Swiech, K., et al. (2020). Targeted uptake of folic acid-functionalized polymeric nanoparticles loading glycoalkaloidic extract in vitro and in vivo assays. Colloids and Surfaces B: Biointerfaces, 192, 1-8. doi:10.1016/j.colsurfb.2020.111106
NLM
Miranda MA, Silva LB, Carvalho I, Amaral RLF do, Paula MH, Swiech K, Bastos JK, Paschoal JAR, Emery F da S, Reis RB dos, Bentley MVLB, Gaspari PDM. Targeted uptake of folic acid-functionalized polymeric nanoparticles loading glycoalkaloidic extract in vitro and in vivo assays [Internet]. Colloids and Surfaces B: Biointerfaces. 2020 ; 192 1-8.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111106
Vancouver
Miranda MA, Silva LB, Carvalho I, Amaral RLF do, Paula MH, Swiech K, Bastos JK, Paschoal JAR, Emery F da S, Reis RB dos, Bentley MVLB, Gaspari PDM. Targeted uptake of folic acid-functionalized polymeric nanoparticles loading glycoalkaloidic extract in vitro and in vivo assays [Internet]. Colloids and Surfaces B: Biointerfaces. 2020 ; 192 1-8.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111106
Artigo de periodico
Synthesis and evaluation of [18F]FEtLos and [18F]AMBF3Los as novel 18F-Labelled Losartan derivatives for molecular imaging of Angiotensin II type 1 receptors (2020)
Ortega Pijeira, Martha Sahylí; Nunes, Paulo Sérgio Gonçalves ; Santos, Sofia Nascimento dos; Zhang, Zhengxing; Pérez Nario, Arian; Perini, Efrain Araujo; Turato, Walter Miguel; Rodríguez Riera, Zalua; Chammas, Roger ; Elsinga, Philip H.; Lin, Kuo-Shyan ; Carvalho, Ivone ; Bernardes, Emerson Soares
Source: Molecules. Unidades: FCF, FM, FCFRP
Subjects: ANGIOTENSINA II, RECEPTORES DE ANGIOTENSINA, DOENÇAS CARDIOVASCULARES, INFLAMAÇÃO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORTEGA PIJEIRA, Martha Sahylí et al. Synthesis and evaluation of [18F]FEtLos and [18F]AMBF3Los as novel 18F-Labelled Losartan derivatives for molecular imaging of Angiotensin II type 1 receptors. Molecules, v. 25, n. 8, p. 1-21, 2020Tradução . . Disponível em: https://doi.org/10.3390/molecules25081872. Acesso em: 01 nov. 2024.
APA
Ortega Pijeira, M. S., Nunes, P. S. G., Santos, S. N. dos, Zhang, Z., Pérez Nario, A., Perini, E. A., et al. (2020). Synthesis and evaluation of [18F]FEtLos and [18F]AMBF3Los as novel 18F-Labelled Losartan derivatives for molecular imaging of Angiotensin II type 1 receptors. Molecules, 25( 8), 1-21. doi:10.3390/molecules25081872
NLM
Ortega Pijeira MS, Nunes PSG, Santos SN dos, Zhang Z, Pérez Nario A, Perini EA, Turato WM, Rodríguez Riera Z, Chammas R, Elsinga PH, Lin K-S, Carvalho I, Bernardes ES. Synthesis and evaluation of [18F]FEtLos and [18F]AMBF3Los as novel 18F-Labelled Losartan derivatives for molecular imaging of Angiotensin II type 1 receptors [Internet]. Molecules. 2020 ; 25( 8): 1-21.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/molecules25081872
Vancouver
Ortega Pijeira MS, Nunes PSG, Santos SN dos, Zhang Z, Pérez Nario A, Perini EA, Turato WM, Rodríguez Riera Z, Chammas R, Elsinga PH, Lin K-S, Carvalho I, Bernardes ES. Synthesis and evaluation of [18F]FEtLos and [18F]AMBF3Los as novel 18F-Labelled Losartan derivatives for molecular imaging of Angiotensin II type 1 receptors [Internet]. Molecules. 2020 ; 25( 8): 1-21.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/molecules25081872
Artigo de periodico
Iminosugars: effects of stereochemistry, ring size, and N-Substituents on glucosidase activities (2019)
Zamoner, Luís Otavio Bunhotto; Leoneti, Valquiria Aragão; Carvalho, Ivone
Source: Pharmaceuticals. Unidade: FCFRP
Subjects: FÁRMACOS IMUNOSSUPRESSORES, TERAPÊUTICA, ESTEREOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMONER, Luís Otavio Bunhotto e LEONETI, Valquiria Aragão e CARVALHO, Ivone. Iminosugars: effects of stereochemistry, ring size, and N-Substituents on glucosidase activities. Pharmaceuticals, v. 12, n. 3, p. [14] , 2019Tradução . . Disponível em: https://doi.org/10.3390/ph12030108. Acesso em: 01 nov. 2024.
APA
Zamoner, L. O. B., Leoneti, V. A., & Carvalho, I. (2019). Iminosugars: effects of stereochemistry, ring size, and N-Substituents on glucosidase activities. Pharmaceuticals, 12( 3), [14] . doi:10.3390/ph12030108
NLM
Zamoner LOB, Leoneti VA, Carvalho I. Iminosugars: effects of stereochemistry, ring size, and N-Substituents on glucosidase activities [Internet]. Pharmaceuticals. 2019 ; 12( 3): [14] .[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/ph12030108
Vancouver
Zamoner LOB, Leoneti VA, Carvalho I. Iminosugars: effects of stereochemistry, ring size, and N-Substituents on glucosidase activities [Internet]. Pharmaceuticals. 2019 ; 12( 3): [14] .[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/ph12030108
Artigo de periodico
Novel glucopyranoside C2-derived 1,2,3-triazoles displaying selective inhibition of O-GlcNAcase (OGA) (2019)
Igual, Michelle Ogava; Nunes, Paulo Sergio Gonçalves; Costa, Rafael Menezes da ; Mantoani, Susimaire Pedersoli; Tostes, Rita de Cássia Aleixo ; Carvalho, Ivone
Source: Carbohydrate Research. Unidades: FMRP, FCFRP
Subjects: SOBREVIVÊNCIA CELULAR, CÉLULAS CULTIVADAS, INIBIDORES DE ENZIMAS, ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA), MÚSCULO LISO VASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IGUAL, Michelle Ogava et al. Novel glucopyranoside C2-derived 1,2,3-triazoles displaying selective inhibition of O-GlcNAcase (OGA). Carbohydrate Research, v. 471, p. 43-55, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.carres.2018.10.007. Acesso em: 01 nov. 2024.
APA
Igual, M. O., Nunes, P. S. G., Costa, R. M. da, Mantoani, S. P., Tostes, R. de C. A., & Carvalho, I. (2019). Novel glucopyranoside C2-derived 1,2,3-triazoles displaying selective inhibition of O-GlcNAcase (OGA). Carbohydrate Research, 471, 43-55. doi:10.1016/j.carres.2018.10.007
NLM
Igual MO, Nunes PSG, Costa RM da, Mantoani SP, Tostes R de CA, Carvalho I. Novel glucopyranoside C2-derived 1,2,3-triazoles displaying selective inhibition of O-GlcNAcase (OGA) [Internet]. Carbohydrate Research. 2019 ; 471 43-55.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.carres.2018.10.007
Vancouver
Igual MO, Nunes PSG, Costa RM da, Mantoani SP, Tostes R de CA, Carvalho I. Novel glucopyranoside C2-derived 1,2,3-triazoles displaying selective inhibition of O-GlcNAcase (OGA) [Internet]. Carbohydrate Research. 2019 ; 471 43-55.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.carres.2018.10.007
Artigo de periodico
Protozoan parasites glycosylphosphatidylinositol anchors: structures, functions and trends for drug discovery (2019)
Morotti, Ana Luísa Malaco; Martins-Teixeira, Maristela Braga; Carvalho, Ivone
Source: Current Medicinal Chemistry. Unidade: FCFRP
Subjects: IMUNOTERAPIA, PROTOZOA, FOSFOLIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOROTTI, Ana Luísa Malaco e MARTINS-TEIXEIRA, Maristela Braga e CARVALHO, Ivone. Protozoan parasites glycosylphosphatidylinositol anchors: structures, functions and trends for drug discovery. Current Medicinal Chemistry, v. 26, p. 4301-4322, 2019Tradução . . Disponível em: https://doi.org/10.2174/0929867324666170727110801. Acesso em: 01 nov. 2024.
APA
Morotti, A. L. M., Martins-Teixeira, M. B., & Carvalho, I. (2019). Protozoan parasites glycosylphosphatidylinositol anchors: structures, functions and trends for drug discovery. Current Medicinal Chemistry, 26, 4301-4322. doi:10.2174/0929867324666170727110801
NLM
Morotti ALM, Martins-Teixeira MB, Carvalho I. Protozoan parasites glycosylphosphatidylinositol anchors: structures, functions and trends for drug discovery [Internet]. Current Medicinal Chemistry. 2019 ; 26 4301-4322.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/0929867324666170727110801
Vancouver
Morotti ALM, Martins-Teixeira MB, Carvalho I. Protozoan parasites glycosylphosphatidylinositol anchors: structures, functions and trends for drug discovery [Internet]. Current Medicinal Chemistry. 2019 ; 26 4301-4322.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/0929867324666170727110801
Artigo de periodico
Potential Triazole-based molecules for the treatment of neglected diseases (2019)
Mantoani, Susimaire Pedersoli; Andrade, Peterson de; Chierrito, Talita Perez Cantuaria; Figueredo, Andreza da Silva ; Carvalho, Ivone
Source: Current Medicinal Chemistry. Unidade: FCFRP
Subjects: LEISHMANIOSE CUTÂNEA, DOENÇAS NEGLIGENCIADAS, DOENÇA DE CHAGAS, MALÁRIA, TUBERCULOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANTOANI, Susimaire Pedersoli et al. Potential Triazole-based molecules for the treatment of neglected diseases. Current Medicinal Chemistry, v. 26, n. 23, p. 4403-4434, 2019Tradução . . Disponível em: https://doi.org/10.2174/0929867324666170727103901. Acesso em: 01 nov. 2024.
APA
Mantoani, S. P., Andrade, P. de, Chierrito, T. P. C., Figueredo, A. da S., & Carvalho, I. (2019). Potential Triazole-based molecules for the treatment of neglected diseases. Current Medicinal Chemistry, 26( 23), 4403-4434. doi:10.2174/0929867324666170727103901
NLM
Mantoani SP, Andrade P de, Chierrito TPC, Figueredo A da S, Carvalho I. Potential Triazole-based molecules for the treatment of neglected diseases [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4403-4434.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/0929867324666170727103901
Vancouver
Mantoani SP, Andrade P de, Chierrito TPC, Figueredo A da S, Carvalho I. Potential Triazole-based molecules for the treatment of neglected diseases [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4403-4434.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/0929867324666170727103901
Artigo de periodico
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease (2019)
Andrade, Peterson de; Mantoani, Susimaire Pedersoli; Nunes, Paulo Sergio Gonçalves; Magadán, Carlos Roca; Perez, Concepción; Xavier, Danilo Jordão; Sakamoto-Hojo, Elza Tiemi ; Campillo, Nuria E.; Martínez, Ana; Carvalho, Ivone
Source: Bioorganic & Medicinal Chemistry. Unidades: FFCLRP, FCFRP
Subjects: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS, SÍNTESE QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Peterson de et al. Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease. Bioorganic & Medicinal Chemistry, v. 27, n. 6, p. 931-943, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2018.12.030. Acesso em: 01 nov. 2024.
APA
Andrade, P. de, Mantoani, S. P., Nunes, P. S. G., Magadán, C. R., Perez, C., Xavier, D. J., et al. (2019). Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease. Bioorganic & Medicinal Chemistry, 27( 6), 931-943. doi:10.1016/j.bmc.2018.12.030
NLM
Andrade P de, Mantoani SP, Nunes PSG, Magadán CR, Perez C, Xavier DJ, Sakamoto-Hojo ET, Campillo NE, Martínez A, Carvalho I. Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease [Internet]. Bioorganic & Medicinal Chemistry. 2019 ; 27( 6): 931-943.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bmc.2018.12.030
Vancouver
Andrade P de, Mantoani SP, Nunes PSG, Magadán CR, Perez C, Xavier DJ, Sakamoto-Hojo ET, Campillo NE, Martínez A, Carvalho I. Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease [Internet]. Bioorganic & Medicinal Chemistry. 2019 ; 27( 6): 931-943.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bmc.2018.12.030
Artigo de periodico
Galactosyl and sialyl clusters: synthesis and evaluation against T. cruzi parasite (2019)
Figueredo, Andreza da Silva ; Andrade, Peterson de; Riul, Thalita Bachelli ; Marchiori, Marcelo Fiori ; Leo, Thais Canassa de ; Fleuri, Anna Karoline Aguiar; Schenkman, Sérgio; Baruffi, Marcelo Dias ; Carvalho, Ivone
Source: Pure and Applied Chemistry. Unidade: FCFRP
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FIGUEREDO, Andreza da Silva et al. Galactosyl and sialyl clusters: synthesis and evaluation against T. cruzi parasite. Pure and Applied Chemistry, v. 91, n. 7, p. 1191-1207, 2019Tradução . . Disponível em: https://doi.org/10.1515/pac-2019-0216. Acesso em: 01 nov. 2024.
APA
Figueredo, A. da S., Andrade, P. de, Riul, T. B., Marchiori, M. F., Leo, T. C. de, Fleuri, A. K. A., et al. (2019). Galactosyl and sialyl clusters: synthesis and evaluation against T. cruzi parasite. Pure and Applied Chemistry, 91( 7), 1191-1207. doi:10.1515/pac-2019-0216
NLM
Figueredo A da S, Andrade P de, Riul TB, Marchiori MF, Leo TC de, Fleuri AKA, Schenkman S, Baruffi MD, Carvalho I. Galactosyl and sialyl clusters: synthesis and evaluation against T. cruzi parasite [Internet]. Pure and Applied Chemistry. 2019 ; 91( 7): 1191-1207.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1515/pac-2019-0216
Vancouver
Figueredo A da S, Andrade P de, Riul TB, Marchiori MF, Leo TC de, Fleuri AKA, Schenkman S, Baruffi MD, Carvalho I. Galactosyl and sialyl clusters: synthesis and evaluation against T. cruzi parasite [Internet]. Pure and Applied Chemistry. 2019 ; 91( 7): 1191-1207.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1515/pac-2019-0216
Artigo de periodico
Insights into anti-trypanosomal agents based on synthetic glycoconjugates (2018)
Campo, Vanessa Leiria; Marchiori, Marcelo Fiori; Carvalho, Ivone
Source: Current Topics in Medicinal Chemistry. Unidade: FCFRP
Subjects: TRIPANOSSOMICIDAS, DOENÇAS DE CHAGAS, GLICOCONJUGADOS, TRYPANOSOMA CRUZI, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPO, Vanessa Leiria e MARCHIORI, Marcelo Fiori e CARVALHO, Ivone. Insights into anti-trypanosomal agents based on synthetic glycoconjugates. Current Topics in Medicinal Chemistry, v. 18, n. 5, p. 382-396, 2018Tradução . . Disponível em: https://doi.org/10.2174/1568026618666180509145305. Acesso em: 01 nov. 2024.
APA
Campo, V. L., Marchiori, M. F., & Carvalho, I. (2018). Insights into anti-trypanosomal agents based on synthetic glycoconjugates. Current Topics in Medicinal Chemistry, 18( 5), 382-396. doi:10.2174/1568026618666180509145305
NLM
Campo VL, Marchiori MF, Carvalho I. Insights into anti-trypanosomal agents based on synthetic glycoconjugates [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18( 5): 382-396.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/1568026618666180509145305
Vancouver
Campo VL, Marchiori MF, Carvalho I. Insights into anti-trypanosomal agents based on synthetic glycoconjugates [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18( 5): 382-396.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/1568026618666180509145305
Artigo de periodico
Synthesis and evaluation of an 18 F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography (2018)
Nunes, Paulo Sergio Gonçalves; Zhang, Zhengxing; Kuo, Hsiou-Ting; Zhang, Chengcheng; Rousseau, Julie; Rousseau, Etienne; Lau, Joseph; Kwon, Daniel; Carvalho, Ivone ; Bénard, François; Lin, Kuo-Shyan
Source: Journal of Labelled Compounds and Radiopharmaceuticals. Unidade: FCFRP
Subjects: FLÚOR, ANÓXIA, TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE PÓSITRON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Paulo Sergio Gonçalves et al. Synthesis and evaluation of an 18 F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography. Journal of Labelled Compounds and Radiopharmaceuticals, v. 61, p. 370-379, 2018Tradução . . Disponível em: https://doi.org/10.1002/jlcr.3594. Acesso em: 01 nov. 2024.
APA
Nunes, P. S. G., Zhang, Z., Kuo, H. -T., Zhang, C., Rousseau, J., Rousseau, E., et al. (2018). Synthesis and evaluation of an 18 F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography. Journal of Labelled Compounds and Radiopharmaceuticals, 61, 370-379. doi:10.1002/jlcr.3594
NLM
Nunes PSG, Zhang Z, Kuo H-T, Zhang C, Rousseau J, Rousseau E, Lau J, Kwon D, Carvalho I, Bénard F, Lin K-S. Synthesis and evaluation of an 18 F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography [Internet]. Journal of Labelled Compounds and Radiopharmaceuticals. 2018 ; 61 370-379.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jlcr.3594
Vancouver
Nunes PSG, Zhang Z, Kuo H-T, Zhang C, Rousseau J, Rousseau E, Lau J, Kwon D, Carvalho I, Bénard F, Lin K-S. Synthesis and evaluation of an 18 F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography [Internet]. Journal of Labelled Compounds and Radiopharmaceuticals. 2018 ; 61 370-379.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jlcr.3594
Artigo de periodico
Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: potent butyrylcholinesterase inhibitors (2018)
Chierrito, Talita Perez Cantuaria; Pedersoli-Mantoani, Susimaire; Roca, Carlos; Sebastian-Pérez, Victor; Martínez-Gonzalez, Loreto; Pérez, Daniel I.; Perez, Concepción; Canales, Angeles; Cañada, F. Javier; Campillo, Nuria E.; Carvalho, Ivone; Martinez, Ana
Source: European Journal of Medicinal Chemistry. Unidade: FCFRP
Subjects: DOENÇA DE ALZHEIMER, FARMACOTÉCNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHIERRITO, Talita Perez Cantuaria et al. Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: potent butyrylcholinesterase inhibitors. European Journal of Medicinal Chemistry, v. 145, p. 431-444, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2018.01.007. Acesso em: 01 nov. 2024.
APA
Chierrito, T. P. C., Pedersoli-Mantoani, S., Roca, C., Sebastian-Pérez, V., Martínez-Gonzalez, L., Pérez, D. I., et al. (2018). Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: potent butyrylcholinesterase inhibitors. European Journal of Medicinal Chemistry, 145, 431-444. doi:10.1016/j.ejmech.2018.01.007
NLM
Chierrito TPC, Pedersoli-Mantoani S, Roca C, Sebastian-Pérez V, Martínez-Gonzalez L, Pérez DI, Perez C, Canales A, Cañada FJ, Campillo NE, Carvalho I, Martinez A. Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: potent butyrylcholinesterase inhibitors [Internet]. European Journal of Medicinal Chemistry. 2018 ; 145 431-444.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejmech.2018.01.007
Vancouver
Chierrito TPC, Pedersoli-Mantoani S, Roca C, Sebastian-Pérez V, Martínez-Gonzalez L, Pérez DI, Perez C, Canales A, Cañada FJ, Campillo NE, Carvalho I, Martinez A. Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: potent butyrylcholinesterase inhibitors [Internet]. European Journal of Medicinal Chemistry. 2018 ; 145 431-444.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejmech.2018.01.007
Artigo de periodico
Beyond the "Lock and Key" paradigm: targeting lipid rafts to induce the selective apoptosis of cancer cells (2018)
Alves, Ana Carolina Schineider; Dias Júnior, Reinaldo Antonio; Kagami, Luciano Porto; Neves, Gustavo Machado das; Torres, Fernando Cidade; Eifler-Lima, Vera Lúcia; Carvalho, Ivone ; Silva, Carolina de Miranda; Kawano, Daniel Fábio
Source: Current Medicinal Chemistry. Unidade: FCFRP
Subjects: APOPTOSE, ANTINEOPLÁSICOS, NEOPLASIAS, FOSFOLIPÍDEOS, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Ana Carolina Schineider et al. Beyond the "Lock and Key" paradigm: targeting lipid rafts to induce the selective apoptosis of cancer cells. Current Medicinal Chemistry, v. 25, p. 2082-2104, 2018Tradução . . Disponível em: https://doi.org/10.2174/0929867325666180111100601. Acesso em: 01 nov. 2024.
APA
Alves, A. C. S., Dias Júnior, R. A., Kagami, L. P., Neves, G. M. das, Torres, F. C., Eifler-Lima, V. L., et al. (2018). Beyond the "Lock and Key" paradigm: targeting lipid rafts to induce the selective apoptosis of cancer cells. Current Medicinal Chemistry, 25, 2082-2104. doi:10.2174/0929867325666180111100601
NLM
Alves ACS, Dias Júnior RA, Kagami LP, Neves GM das, Torres FC, Eifler-Lima VL, Carvalho I, Silva C de M, Kawano DF. Beyond the "Lock and Key" paradigm: targeting lipid rafts to induce the selective apoptosis of cancer cells [Internet]. Current Medicinal Chemistry. 2018 ; 25 2082-2104.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/0929867325666180111100601
Vancouver
Alves ACS, Dias Júnior RA, Kagami LP, Neves GM das, Torres FC, Eifler-Lima VL, Carvalho I, Silva C de M, Kawano DF. Beyond the "Lock and Key" paradigm: targeting lipid rafts to induce the selective apoptosis of cancer cells [Internet]. Current Medicinal Chemistry. 2018 ; 25 2082-2104.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/0929867325666180111100601
Artigo de periodico
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease (2017)
Chierrito, Talita P. C.; Mantoani, Susimaire Pedersoli; Roca, Carlos; Requena, Carlos; Perez, Victor Sebastian; Castillo, Willian O.; Moreira, Natalia C. S.; Pérez, Concepción; Sakamoto-Hojo, Elza Tiemi; Takahashi, Catarina Satie; Barbero, Jesús Jiménez; Cañada, F. Javier; Campillo, Nuria E.; Martinez, Ana; Carvalho, Ivone
Source: European Journal of Medicinal Chemistry. Unidades: FFCLRP, FCFRP
Subjects: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHIERRITO, Talita P. C. et al. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease. European Journal of Medicinal Chemistry, v. 139, p. 773-791, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2017.08.051. Acesso em: 01 nov. 2024.
APA
Chierrito, T. P. C., Mantoani, S. P., Roca, C., Requena, C., Perez, V. S., Castillo, W. O., et al. (2017). From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease. European Journal of Medicinal Chemistry, 139, 773-791. doi:10.1016/j.ejmech.2017.08.051
NLM
Chierrito TPC, Mantoani SP, Roca C, Requena C, Perez VS, Castillo WO, Moreira NCS, Pérez C, Sakamoto-Hojo ET, Takahashi CS, Barbero JJ, Cañada FJ, Campillo NE, Martinez A, Carvalho I. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease [Internet]. European Journal of Medicinal Chemistry. 2017 ; 139 773-791.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejmech.2017.08.051
Vancouver
Chierrito TPC, Mantoani SP, Roca C, Requena C, Perez VS, Castillo WO, Moreira NCS, Pérez C, Sakamoto-Hojo ET, Takahashi CS, Barbero JJ, Cañada FJ, Campillo NE, Martinez A, Carvalho I. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease [Internet]. European Journal of Medicinal Chemistry. 2017 ; 139 773-791.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejmech.2017.08.051

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration